| <p>Indegene Limited announced that the merger of Indegene Healthcare Germany GmbH and Trilogy Writing & Consulting GmbH, both indirect wholly owned subsidiaries of Indegene Limited in Germany, was registered with the Commercial Register of the Local Court (Amtsgericht) of Frankfurt am Main on September 9, 2026, making the merger effective on the same date. Following the merger, Trilogy Writing & Consulting GmbH became Indegene Healthcare Germany GmbH, and the combined entity is projected to have a revenue of Euro 20,100,000 for fiscal year 2026-27, with the company stating the reorganization has no material impact on its business operations, shareholding pattern, or financial position.</p> |